| Bernard T Mcnamara, MD | |
|
1241 S Glendale Ave Ste 201, Glendale, CA 91205-3388 | |
| (818) 244-5444 | |
| Not Available |
| Full Name | Bernard T Mcnamara |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 47 Years |
| Location | 1241 S Glendale Ave Ste 201, Glendale, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255351573 | NPI | - | NPPES |
| 00G368380 | Other | CA | BLUE SHIELD |
| 00G368380 | Medicaid | CA | |
| 930128595 | Other | CA | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | G36838 (California) | Secondary |
| 207R00000X | Internal Medicine | G36838 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ahmc Anaheim Regional Medical Center | Anaheim, CA | Hospital |
| Foothill Regional Medical Center | Tustin, CA | Hospital |
| Entity Name | East Valley Emergency Medical Associates, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346287430 PECOS PAC ID: 3870579691 Enrollment ID: O20050506000210 |
News Archive
In recent years reimbursement for surgical services has declined, failing to keep up with inflation and economic growth. Financial incentives aimed at re-distributing reimbursement from procedural specialties to primary care specialties have been ineffective thus far, and the financial returns of being a physician continue to decrease, according to new research published in the April 2011 issue of Otolaryngology - Head and Neck Surgery.
New cases of leprosy are decreasing, but not at the anticipated rate. In order to accelerate the annual decline, countries should screen contacts and treat eligible contacts with single-dose rifampicin, as recommended by the World Health Organization in its guidelines.
In collaboration with Novo Biosciences, Inc., LSU Health New Orleans Cardiovascular Center of Excellence will receive more $500,000 over two years to study the effectiveness of a novel drug designed to stimulate the regeneration of heart muscle and prevent the formation or scar tissue following a heart attack.
University of Texas at Arlington researchers are using an advanced computational approach or artificial intelligence to help experts assess learning difficulties in children very early in their lives.
Arrowhead Research Corporation today announced that its wholly owned subsidiary, Tego Biosciences, has completed a definitive asset purchase agreement for the sale of its non-cash intellectual property (IP) to Luna Innovations, Inc., a developer and manufacturer of new-generation products that include pharmaceutical nanomedicines
› Verified 4 days ago
| Entity Name | Golden West Emergency Medical Associates, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053680298 PECOS PAC ID: 8628098936 Enrollment ID: O20051201000582 |
News Archive
In recent years reimbursement for surgical services has declined, failing to keep up with inflation and economic growth. Financial incentives aimed at re-distributing reimbursement from procedural specialties to primary care specialties have been ineffective thus far, and the financial returns of being a physician continue to decrease, according to new research published in the April 2011 issue of Otolaryngology - Head and Neck Surgery.
New cases of leprosy are decreasing, but not at the anticipated rate. In order to accelerate the annual decline, countries should screen contacts and treat eligible contacts with single-dose rifampicin, as recommended by the World Health Organization in its guidelines.
In collaboration with Novo Biosciences, Inc., LSU Health New Orleans Cardiovascular Center of Excellence will receive more $500,000 over two years to study the effectiveness of a novel drug designed to stimulate the regeneration of heart muscle and prevent the formation or scar tissue following a heart attack.
University of Texas at Arlington researchers are using an advanced computational approach or artificial intelligence to help experts assess learning difficulties in children very early in their lives.
Arrowhead Research Corporation today announced that its wholly owned subsidiary, Tego Biosciences, has completed a definitive asset purchase agreement for the sale of its non-cash intellectual property (IP) to Luna Innovations, Inc., a developer and manufacturer of new-generation products that include pharmaceutical nanomedicines
› Verified 4 days ago
| Entity Name | California Hospitalists Emergency Physicians Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760648539 PECOS PAC ID: 5193886505 Enrollment ID: O20081203000866 |
News Archive
In recent years reimbursement for surgical services has declined, failing to keep up with inflation and economic growth. Financial incentives aimed at re-distributing reimbursement from procedural specialties to primary care specialties have been ineffective thus far, and the financial returns of being a physician continue to decrease, according to new research published in the April 2011 issue of Otolaryngology - Head and Neck Surgery.
New cases of leprosy are decreasing, but not at the anticipated rate. In order to accelerate the annual decline, countries should screen contacts and treat eligible contacts with single-dose rifampicin, as recommended by the World Health Organization in its guidelines.
In collaboration with Novo Biosciences, Inc., LSU Health New Orleans Cardiovascular Center of Excellence will receive more $500,000 over two years to study the effectiveness of a novel drug designed to stimulate the regeneration of heart muscle and prevent the formation or scar tissue following a heart attack.
University of Texas at Arlington researchers are using an advanced computational approach or artificial intelligence to help experts assess learning difficulties in children very early in their lives.
Arrowhead Research Corporation today announced that its wholly owned subsidiary, Tego Biosciences, has completed a definitive asset purchase agreement for the sale of its non-cash intellectual property (IP) to Luna Innovations, Inc., a developer and manufacturer of new-generation products that include pharmaceutical nanomedicines
› Verified 4 days ago
| Entity Name | Culver Emergency Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699907923 PECOS PAC ID: 0244378677 Enrollment ID: O20091105000182 |
News Archive
In recent years reimbursement for surgical services has declined, failing to keep up with inflation and economic growth. Financial incentives aimed at re-distributing reimbursement from procedural specialties to primary care specialties have been ineffective thus far, and the financial returns of being a physician continue to decrease, according to new research published in the April 2011 issue of Otolaryngology - Head and Neck Surgery.
New cases of leprosy are decreasing, but not at the anticipated rate. In order to accelerate the annual decline, countries should screen contacts and treat eligible contacts with single-dose rifampicin, as recommended by the World Health Organization in its guidelines.
In collaboration with Novo Biosciences, Inc., LSU Health New Orleans Cardiovascular Center of Excellence will receive more $500,000 over two years to study the effectiveness of a novel drug designed to stimulate the regeneration of heart muscle and prevent the formation or scar tissue following a heart attack.
University of Texas at Arlington researchers are using an advanced computational approach or artificial intelligence to help experts assess learning difficulties in children very early in their lives.
Arrowhead Research Corporation today announced that its wholly owned subsidiary, Tego Biosciences, has completed a definitive asset purchase agreement for the sale of its non-cash intellectual property (IP) to Luna Innovations, Inc., a developer and manufacturer of new-generation products that include pharmaceutical nanomedicines
› Verified 4 days ago
| Entity Name | Huntington Park Emergency Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053747121 PECOS PAC ID: 9638305204 Enrollment ID: O20131204001371 |
News Archive
In recent years reimbursement for surgical services has declined, failing to keep up with inflation and economic growth. Financial incentives aimed at re-distributing reimbursement from procedural specialties to primary care specialties have been ineffective thus far, and the financial returns of being a physician continue to decrease, according to new research published in the April 2011 issue of Otolaryngology - Head and Neck Surgery.
New cases of leprosy are decreasing, but not at the anticipated rate. In order to accelerate the annual decline, countries should screen contacts and treat eligible contacts with single-dose rifampicin, as recommended by the World Health Organization in its guidelines.
In collaboration with Novo Biosciences, Inc., LSU Health New Orleans Cardiovascular Center of Excellence will receive more $500,000 over two years to study the effectiveness of a novel drug designed to stimulate the regeneration of heart muscle and prevent the formation or scar tissue following a heart attack.
University of Texas at Arlington researchers are using an advanced computational approach or artificial intelligence to help experts assess learning difficulties in children very early in their lives.
Arrowhead Research Corporation today announced that its wholly owned subsidiary, Tego Biosciences, has completed a definitive asset purchase agreement for the sale of its non-cash intellectual property (IP) to Luna Innovations, Inc., a developer and manufacturer of new-generation products that include pharmaceutical nanomedicines
› Verified 4 days ago
| Entity Name | Can Emergency Physicians Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265810006 PECOS PAC ID: 8820304462 Enrollment ID: O20150827002595 |
News Archive
In recent years reimbursement for surgical services has declined, failing to keep up with inflation and economic growth. Financial incentives aimed at re-distributing reimbursement from procedural specialties to primary care specialties have been ineffective thus far, and the financial returns of being a physician continue to decrease, according to new research published in the April 2011 issue of Otolaryngology - Head and Neck Surgery.
New cases of leprosy are decreasing, but not at the anticipated rate. In order to accelerate the annual decline, countries should screen contacts and treat eligible contacts with single-dose rifampicin, as recommended by the World Health Organization in its guidelines.
In collaboration with Novo Biosciences, Inc., LSU Health New Orleans Cardiovascular Center of Excellence will receive more $500,000 over two years to study the effectiveness of a novel drug designed to stimulate the regeneration of heart muscle and prevent the formation or scar tissue following a heart attack.
University of Texas at Arlington researchers are using an advanced computational approach or artificial intelligence to help experts assess learning difficulties in children very early in their lives.
Arrowhead Research Corporation today announced that its wholly owned subsidiary, Tego Biosciences, has completed a definitive asset purchase agreement for the sale of its non-cash intellectual property (IP) to Luna Innovations, Inc., a developer and manufacturer of new-generation products that include pharmaceutical nanomedicines
› Verified 4 days ago
| Entity Name | Dr. Bernard Mcnamara Md Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952849473 PECOS PAC ID: 4284918954 Enrollment ID: O20170223001819 |
News Archive
In recent years reimbursement for surgical services has declined, failing to keep up with inflation and economic growth. Financial incentives aimed at re-distributing reimbursement from procedural specialties to primary care specialties have been ineffective thus far, and the financial returns of being a physician continue to decrease, according to new research published in the April 2011 issue of Otolaryngology - Head and Neck Surgery.
New cases of leprosy are decreasing, but not at the anticipated rate. In order to accelerate the annual decline, countries should screen contacts and treat eligible contacts with single-dose rifampicin, as recommended by the World Health Organization in its guidelines.
In collaboration with Novo Biosciences, Inc., LSU Health New Orleans Cardiovascular Center of Excellence will receive more $500,000 over two years to study the effectiveness of a novel drug designed to stimulate the regeneration of heart muscle and prevent the formation or scar tissue following a heart attack.
University of Texas at Arlington researchers are using an advanced computational approach or artificial intelligence to help experts assess learning difficulties in children very early in their lives.
Arrowhead Research Corporation today announced that its wholly owned subsidiary, Tego Biosciences, has completed a definitive asset purchase agreement for the sale of its non-cash intellectual property (IP) to Luna Innovations, Inc., a developer and manufacturer of new-generation products that include pharmaceutical nanomedicines
› Verified 4 days ago
| Entity Name | Gold Care Golden State Medical |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356929558 PECOS PAC ID: 7113328253 Enrollment ID: O20210628001821 |
News Archive
In recent years reimbursement for surgical services has declined, failing to keep up with inflation and economic growth. Financial incentives aimed at re-distributing reimbursement from procedural specialties to primary care specialties have been ineffective thus far, and the financial returns of being a physician continue to decrease, according to new research published in the April 2011 issue of Otolaryngology - Head and Neck Surgery.
New cases of leprosy are decreasing, but not at the anticipated rate. In order to accelerate the annual decline, countries should screen contacts and treat eligible contacts with single-dose rifampicin, as recommended by the World Health Organization in its guidelines.
In collaboration with Novo Biosciences, Inc., LSU Health New Orleans Cardiovascular Center of Excellence will receive more $500,000 over two years to study the effectiveness of a novel drug designed to stimulate the regeneration of heart muscle and prevent the formation or scar tissue following a heart attack.
University of Texas at Arlington researchers are using an advanced computational approach or artificial intelligence to help experts assess learning difficulties in children very early in their lives.
Arrowhead Research Corporation today announced that its wholly owned subsidiary, Tego Biosciences, has completed a definitive asset purchase agreement for the sale of its non-cash intellectual property (IP) to Luna Innovations, Inc., a developer and manufacturer of new-generation products that include pharmaceutical nanomedicines
› Verified 4 days ago
| Entity Name | Anaheim Emergency Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114626017 PECOS PAC ID: 9133585029 Enrollment ID: O20230518003235 |
News Archive
In recent years reimbursement for surgical services has declined, failing to keep up with inflation and economic growth. Financial incentives aimed at re-distributing reimbursement from procedural specialties to primary care specialties have been ineffective thus far, and the financial returns of being a physician continue to decrease, according to new research published in the April 2011 issue of Otolaryngology - Head and Neck Surgery.
New cases of leprosy are decreasing, but not at the anticipated rate. In order to accelerate the annual decline, countries should screen contacts and treat eligible contacts with single-dose rifampicin, as recommended by the World Health Organization in its guidelines.
In collaboration with Novo Biosciences, Inc., LSU Health New Orleans Cardiovascular Center of Excellence will receive more $500,000 over two years to study the effectiveness of a novel drug designed to stimulate the regeneration of heart muscle and prevent the formation or scar tissue following a heart attack.
University of Texas at Arlington researchers are using an advanced computational approach or artificial intelligence to help experts assess learning difficulties in children very early in their lives.
Arrowhead Research Corporation today announced that its wholly owned subsidiary, Tego Biosciences, has completed a definitive asset purchase agreement for the sale of its non-cash intellectual property (IP) to Luna Innovations, Inc., a developer and manufacturer of new-generation products that include pharmaceutical nanomedicines
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Bernard T Mcnamara, MD 26895 Aliso Creek Rd Ste B516, Aliso Viejo, CA 92656-5300 Ph: (310) 480-4770 | Bernard T Mcnamara, MD 1241 S Glendale Ave Ste 201, Glendale, CA 91205-3388 Ph: (818) 244-5444 |
News Archive
In recent years reimbursement for surgical services has declined, failing to keep up with inflation and economic growth. Financial incentives aimed at re-distributing reimbursement from procedural specialties to primary care specialties have been ineffective thus far, and the financial returns of being a physician continue to decrease, according to new research published in the April 2011 issue of Otolaryngology - Head and Neck Surgery.
New cases of leprosy are decreasing, but not at the anticipated rate. In order to accelerate the annual decline, countries should screen contacts and treat eligible contacts with single-dose rifampicin, as recommended by the World Health Organization in its guidelines.
In collaboration with Novo Biosciences, Inc., LSU Health New Orleans Cardiovascular Center of Excellence will receive more $500,000 over two years to study the effectiveness of a novel drug designed to stimulate the regeneration of heart muscle and prevent the formation or scar tissue following a heart attack.
University of Texas at Arlington researchers are using an advanced computational approach or artificial intelligence to help experts assess learning difficulties in children very early in their lives.
Arrowhead Research Corporation today announced that its wholly owned subsidiary, Tego Biosciences, has completed a definitive asset purchase agreement for the sale of its non-cash intellectual property (IP) to Luna Innovations, Inc., a developer and manufacturer of new-generation products that include pharmaceutical nanomedicines
› Verified 4 days ago
Tigran Khachatryan, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 660 W Broadway, Glendale, CA 91204 Phone: 818-243-9600 | |
Dr. Jean-pierre E Antaki, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 801 S Chevy Chase Dr, #105, Glendale, CA 91205 Phone: 818-242-5299 Fax: 818-637-7607 | |
Dr. Ellie Bloomfield, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1808 Verdugo Blvd, Suite 403, Glendale, CA 91208 Phone: 818-790-7098 Fax: 818-790-7099 | |
Edgar H Aleman, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 435 Arden Ave, 410, Glendale, CA 91203 Phone: 818-242-4191 Fax: 818-242-4811 | |
Michael Eugene Klein, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1818 Verdugo Blvd, #300, Glendale, CA 91208 Phone: 818-952-5332 Fax: 818-790-6830 | |
Alen Mirzaian, M.D. Internal Medicine Medicare: May Accept Medicare Assignments Practice Location: 1818 Verdugo Blvd Ste 401, Glendale, CA 91208 Phone: 818-790-1145 | |
Dr. Thomas Yarger Pocock, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1809 Verdugo Blvd, #200, Glendale, CA 91208 Phone: 818-790-6700 Fax: 818-790-2816 |